Brief reportDrug-induced insulin autoimmune syndrome
Section snippets
Conflict of interest
There are no conflicts of interest.
References (10)
Methimazole and insulin autoimmune syndrome with hypoglycemia
Lancet
(1983)- et al.
Possible relevance of alpha lipoic acid contained in a health supplement in a care of insulin autoimmune syndrome
Diab Res Clin Prac
(2007) - et al.
Worldwide differences in the incidence of insulin autoimuune syndrome (Hirata Disease) with respect to the evolution of HLA-DR4 alleles
Hum Immunol
(2000) - et al.
Insulin autoimmunity in a case of spontaneous hypoglycemia
J Jpn Diabetes Soc
(1970) - et al.
Strong association of insulin autoimmune syndrome with HLA-DR4
Lancet
(1992)
Cited by (78)
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems
2021, Clinical NutritionCitation Excerpt :These findings are supported by case reports describing proven hypersensitivity reactions to ALA, although no clear pathophysiological mechanism has been identified [44–47]. Insulin autoimmune syndrome, also known as Hirata disease, is a life-threatening AR to ALA-containing dietary supplements, leading to severe hypoglycaemia [13–17]. Although Hirata disease is well-recognised in Japan [48], the diagnosis and imputability to ALA remain challenging in the Western world [49].
Insulin autoimmune syndrome in patients with type 2 diabetes: A report of two cases
2021, Diabetes and MetabolismInsulin Autoimmune Syndrome Diagnosis and Therapy in a Single Chinese Center
2019, Clinical TherapeuticsCitation Excerpt :Hypoglycemia attributable to the development of antibodies to native insulin is reported to occur primarily among Asian populations4 and is reported to be the third most common cause of spontaneous hypoglycemia in Japan.5 Drugs in the sulfur or sulfydryl groups (eg, thiols with -SH), such as methimazole, captopril, hydralazine, glutathione, and clopidogrel,6–8 were deemed to have the potential to trigger IAS. Patients with autoimmune diseases are also more likely to have IAS.
Drug-induced hyperinsulinemic hypoglycemia: An update on pathophysiology and treatment
2023, Reviews in Endocrine and Metabolic Disorders